"Il campus di Roma dell’Università Cattolica del Sacro Cuore, con la Facoltà di Medicina e Chirurgia e la Facoltà di Economia, garantisce un’offerta formativa all’avanguardia, interdisciplinare e sempre più apprezzata da studenti internazionali. Grazie alla prestigiosa partnership con la Fondazione Policlinico Universitario Agostino Gemelli IRCCS, la sinergia tra didattica, ricerca e assistenza sanitaria costituisce un “laboratorio formativo” unico dove gli studenti possono “sperimentare” le conoscenze acquisite in aula confrontandosi con l’attività clinica e la complessità organizzativa e gestionale. Soluzioni architettoniche moderne offrono un ambiente funzionale e accogliente che favorisce la collaborazione e lo scambio culturale."

During the past decade, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 12 clinical trials were completed, i.e. on average, 19.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 40 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 9 trials sponsored, "Incyte Corporation" with 7 trials sponsored, "Catholic University of the Sacred Heart" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" are "Leukemia" (14 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Chronic Myeloid Leukemia" (5 trials), "Acute Promyelocytic Leukemia" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" in a lesser frequency.

Most popular intervention types in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" are "Drug" (79 trials), "Other" (14 trials), "Procedure" (11 trials), "Biological" (8 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "cytarabine" (6 trials), "etoposide" (6 trials), "idarubicin" (6 trials) and "mitoxantrone hydrochloride" (5 trials). Other intervention names were less common.

The vast majority of trials in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli" are 102 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Università Cattolica del Sacro Cuore - Policlinico A. Gemelli". 1 are not yet recruiting, 22 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, 8 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".